CLINICAL_TRIALS
research
· 2019-08-16
Clinical Trial Update: Optimum Thiamine Intervention (OpTIn) Trial [Phase 4]
Summary
Phase 4 trial update for Optimum Thiamine Intervention (OpTIn) investigating thiamine intervention in Wernicke-Korsakoff Syndrome.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Menzies School of Health Research | Conditions: Wernicke-Korsakoff Syndrome | Phase 4 | Status: COMPLETED